Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentJoseph Keane, M. Miles Braun, Sharon K. Gershon et al.|New England Journal of Medicine|2001Cited by 3.7k
Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanerceptJong‐Hoon Lee, M. Miles Braun, Robert P. Wise et al.|Arthritis & Rheumatism|2002Cited by 448
Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor InhibitorAnkith Mohan, M. Miles Braun, Ronald Timothy et al.|Clinical Infectious Diseases|2004Cited by 304
Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.Niveditha Mohan, M. Miles Braun, Evelyne T. Edwards et al.|PubMed|2004Cited by 198
Drug-induced systemic lupus erythematosus and TNF-α blockersAparna Mohan, M. Miles Braun, Evelyne T. Edwards et al.|The Lancet|2002Cited by 82